Fleury SA FLRY3
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- R$23.80
- Day Range
- R$23.20–23.95
- 52-Week Range
- R$13.90–23.95
- Bid/Ask
- R$0.00 / R$0.00
- Shares Outstanding
- 543.63M
- Market Cap
- R$12.78B
- Volume/Avg
- 11M / 4M
Key Statistics
- Price/Earnings (Normalized)
- 19.79
- Price/Sales
- 1.51
- Dividend Yield (Trailing)
- 5.53%
- Dividend Yield (Forward)
- 5.53%
- Dividend Payment Schedule
- Sep
- Total Yield
- 5.53%
Company Profile
Fleury SA is engaged in the provision of medical services in the diagnostic, laboratory support (Lab-to-Lab), infusions, clinical analysis, health management, medical care, orthopedics and ophthalmology, fertility, infusion areas and toxicological exams, among others. The company offers diagnostic medicine through physical service units and mobile diagnostic services for consumers. It also provides diagnostic support services to laboratories and hospitals. In addition, the company operates clinics and services in areas such as infusion therapy, orthopedics, ophthalmology, reproductive medicine, and oncology. It has two reportable business segments: Diagnostic Medicine and Integrated Medicine. The maximum revenue is generated from the Diagnostic Medicine Segment.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Mid Core
- Total Number of Employees
- 23,200
- Website
- https://www.fleury.com.br
Valuation
|
Metric
|
FLRY3
|
|---|---|
Price/Earnings (Normalized) | 19.79 |
Price/Book Value | 2.47 |
Price/Sales | 1.51 |
Price/Cash Flow | 6.79 |
Price/Earnings
FLRY3
Financial Strength
|
Metric
|
FLRY3
|
|---|---|
Quick Ratio | 2.01 |
Current Ratio | 2.14 |
Interest Coverage | 1.72 |
Quick Ratio
FLRY3
Profitability
|
Metric
|
FLRY3
|
|---|---|
Return on Assets (Normalized) | — |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
FLRY3
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| LOCK|Cqwn^#Hg | LOCK|?qx | $242B | |||
| Danaher Corp
DHR
| LOCK|^?d@lT<$ | LOCK|H$& | $150B | |||
| Agilent Technologies Inc
A
| LOCK|><YL??<t | LOCK|l$ | $47B | |||
| IQVIA Holdings Inc
IQV
| LOCK|<d!%<< | LOCK|&>#$ | $43B | |||
| Waters Corp
WAT
| LOCK|F?jDls | LOCK|hL | $42B | |||
| Illumina Inc
ILMN
| LOCK|?fZj#% | LOCK|X$jq# | $41B | |||
| IDEXX Laboratories Inc
IDXX
| LOCK|<?H>!$F | LOCK|pKm | $41B | |||
| Mettler-Toledo International Inc
MTD
| LOCK|&$@wJT@b | LOCK|XM^dr | $30B | |||
| Quest Diagnostics Inc
DGX
| LOCK|Zjc@S@ | LOCK|?tZx | $26B | |||
| Labcorp Holdings Inc
LH
| LOCK|sz?<!@LY | LOCK|f&ZR | $25B |
United States